| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 31.600 | 1.389 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 38.402 | 1.389 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 0 | 28.764 | 3.890 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 0 | 9.638 | -2.502 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 0 | 9.311 | -2.502 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 1 |
Check the financial reports for the company - Melika Prod Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 75 |
| Current Assets | - | - | - | - | - | - | - | 12.142 | 68.143 | 29.426 |
| Inventories | - | - | - | - | - | - | - | 11.208 | 13.879 | 14.969 |
| Receivables | - | - | - | - | - | - | - | 914 | 51.609 | 13.625 |
| Cash | - | - | - | - | - | - | - | 20 | 2.655 | 832 |
| Shareholders Funds | - | - | - | - | - | - | - | 20 | 9.331 | 6.777 |
| Social Capital | - | - | - | - | - | - | - | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | - | 12.122 | 58.812 | 22.724 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Melika Prod Bio S.r.l.